Insiders plan to resell Kymera shares (KYMR) after RSU vesting

Rhea-AI Filing Summary

Kymera Therapeutics reported proposed sales of common stock under a Form 144. The notice lists two batches of shares tied to restricted stock units that vested under the 2020 Equity Incentive Plan: 7,576 shares on 03/01/2026 and 5,000 shares on 03/03/2026. The shares are described as acquired upon vesting and are listed with a broker on NASDAQ.

Insights

Securities Counsel

Form 144 lists proposed resale of vested RSU shares by insiders via a broker.

The filing documents two specific resale batches: 7,576 shares on 03/01/2026 and 5,000 shares on 03/03/2026

These shares are described as acquired upon vesting under the 2020 Equity Incentive Plan; the filing does not state proceeds or whether sales have executed. Subsequent transfers or sales will be reported separately if and when executed.

Equity Compensation Analyst

Vested RSUs converted to shares and registered for resale in modest, defined lots.

The entries tie the shares explicitly to RSU vesting events under the 2020 plan, indicating routine compensation settlement. The sizes—7,576 and 5,000—are specific and limited in scale relative to typical public floats.

Impact depends on whether the broker executes the sales; the filing itself only notifies intent to resell.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza 38th Floor New York NY 10004	12576	1133098	81642394	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/01/2026	Shares acquired upon vesting of Restricted Stock Units awarded under the Issuer's 2020 Equity Incentive Plan.	KYMERA THERAPEUTICS, INC.			7576	03/01/2026	Equity compensation
Common Stock	03/03/2026	Shares acquired upon vesting of Restricted Stock Units awarded under the Issuer's 2020 Equity Incentive Plan.	KYMERA THERAPEUTICS, INC.			5000	03/03/2026	Equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Kymera's (KYMR) Form 144 show?

The Form 144 shows proposed resale of vested RSU shares. It lists 7,576 shares with a vesting date of 03/01/2026 and 5,000 shares with a vesting date of 03/03/2026, both described as acquired under the 2020 Equity Incentive Plan.

Who is handling the share sales in the KYMR Form 144?

A broker is listed for the transactions. The filing names a broker address associated with trading services and indicates the sales are connected to NASDAQ-listed common stock, but it does not disclose the executing broker's trading instructions or sale timings.

Are the shares in Kymera's Form 144 newly issued or from vested RSUs?

The shares were acquired upon vesting of RSUs. The filing explicitly ties the reported share amounts to restricted stock units awarded under the company’s 2020 Equity Incentive Plan, indicating they originated from equity compensation vesting events.

Does the Form 144 state how much Kymera will receive from the sales?

The filing does not state proceeds or prices. The Form 144 lists share counts and vesting dates but contains no information about sale prices or aggregate cash proceeds resulting from any eventual resale transactions.

Will executed sales be reported after this KYMR Form 144?

Yes, executed transactions are typically reported separately. Form 144 notifies intended resale of registered shares; actual sale executions and prices would appear in subsequent market transaction reports or insider filings if required by rules.